Hybrid-APC Margin Ablation to Prevent Post EMR Adenoma Recurrence

NACompletedINTERVENTIONAL
Enrollment

376

Participants

Timeline

Start Date

August 26, 2019

Primary Completion Date

December 13, 2024

Study Completion Date

January 8, 2025

Conditions
Colorectal CancerPolyp of Colon
Interventions
PROCEDURE

Hybrid Argon Plasma Coagulation and EMR procedure

Hybrid Argon Plasma Coagulation (h-APC) combines an ablation technique (APC) with the option for submucosal saline injection using a high-pressure water jet. The technique allows to lift dysplastic epithelium thus creating a safety cushion under the mucosa is lifted with a saline injection and then to ablate larger areas more thoroughly and with a higher energy setting, with a low risk for side effects or complications

Trial Locations (1)

Unknown

Centre Hospitalier Universitaire de Montréal (CHUM), Montreal

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Penn State University

OTHER

collaborator

University of Milan

OTHER

collaborator

Erbe Elektromedizin GmbH

INDUSTRY

collaborator

Unity Health Toronto

OTHER

collaborator

University of British Columbia

OTHER

lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

NCT04015765 - Hybrid-APC Margin Ablation to Prevent Post EMR Adenoma Recurrence | Biotech Hunter | Biotech Hunter